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Recently, four premature ejaculation (PE) subtypes have been distinguished on the ba-
sis of the duration of the intravaginal ejaculation latency time (IELT). These four PE 
subtypes have different etiologies and pathogeneses. Genetic research on PE should 
consider the existence of these PE subtypes and the accurate measurement of the IELT 
with a stopwatch. Currently, three methods of genetic research on PE have been used. 
They differ in the investigated population, tool of measurement, study design, and vari-
ables of PE. From animal and human research, it is derived that the central serotonergic 
system “modulates” ejaculation, whereas the ejaculation (reflex) itself is probably not 
under direct influence of the serotonergic system, but rather under the influence of oth-
er neurotransmitter systems in the spinal cord. For genetic research on PE, it is im-
portant to take into account that the (serotonergic) modulation of the IELT is variable 
among men and may even be absent. This means that serotonergic genetic poly-
morphisms may only be found in men with PE who respond with an ejaculation delay 
on treatment with a selective serotonin reuptake inhibitor.
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INTRODUCTION
In 1998, Waldinger et al postulated that there is a con-
tinuum of the intravaginal ejaculation latency time (IELT) 
in the general male population and that this variability in 
the IELT is influenced by neurobiological and genetic me-
chanisms [1]. In addition, it was postulated that the persis-
tently short IELTs in men with lifelong premature ejacu-
lation (PE) are associated with diminished serotonin (5-hy-
droxytryptamine, or 5-HT) neurotransmission, a hyper-
function of 5-HT1A receptors, and/or a hypofunction of 5- 
HT2C receptors [1]. From the strong ejaculation-delaying 
effects of selective serotonin reuptake inhibitors (SSRIs) 
and particularly that of paroxetine [2], it may be derived 
that serotonin and 5-HT receptors play an important role 
in the ejaculation process, as was already demonstrated in 
rodents in the 1980s [3]. However, for about a decade, the 
details of the neurobiological hypothesis of Waldinger et al 
could not be confirmed in humans owing to the absence of 
specific 5-HT1A and 5-HT2C ligands that were safe for hu-
man use. However, recent genetic research on 5-HT gene 
polymorphisms and the IELT has provided evidence in 
support of the view that the persistently short IELTs in 
men with lifelong PE are associated with decreased 5-HT 
neurotransmission [4]. The idea that PE may have genetic 
roots was suggested for the first time indirectly in 1943, 
when Schapiro noted that family members of men with PE 
also suffered from PE [5]. This remarkable clinical ob-
servation was never quoted in sexological literature until 
1998 when Waldinger et al published a study in which it 
was shown that in first-degree male relatives of men with 
lifelong PE, defined in terms of an IELT of less than 1 mi-
nute, a high percentage of men (91%) also suffered from life-
long PE with an IELT of less than 1 minute [6]. However, 
because only 14 (6%) of 237 men were willing to ask first-de-
gree male relatives about their ejaculation time, this study 
can only be regarded as an indication that the observation 
of Schapiro has some validity. At the same time, the study Korean J Urol 2011;52:1-8
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TABLE 1. New preliminary classification and characteristics of four premature ejaculation subtypes on the basis of their IELT 
durations [14-16]
Lifelong premature 
ejaculation
Acquired premature 
ejaculation
Natural variable premature 
ejaculation
Premature-like 
ejaculatory dysfunction
Ejaculation occurs too early, at 
(nearly) every intercourse
With (nearly) every woman
From about the first sexual en-
counters onwards
In 80% within 1 minute (mostly 
within 30 s)
In 20% between 1 and 2 mi-
nutes
Ejaculation remains rapid 
throughout the lifetime of the 
subject
Early ejaculation occurs at 
some point in a man’s life
The man had normal ejacu-
lation experiences before
The onset is (usually) at later 
age
Ejaculation occurs within 1-2 
minutes 
Rapid ejaculation is result of 
urological, thyroid, or psycho-
logical problems
Early ejaculations are incon-
sistent and occur irregularly
The ability to delay ejaculation 
may be diminished or lacking
From about the first sexual en-
counters or onset at later age
Ejaculation time may be short 
or normal
This is part of the normal varia-
bility of ejaculatory function-
ing
Subjective self-perception of 
(in)consistent rapid ejacu-
lations
The ability to delay ejaculation
may be diminished or lacking
From about the first sexual en-
counters or onset at later age
Ejaculation time is in the nor-
mal range or may even be of 
longer duration
Rapid ejaculation is a subjective
experience independent of ac-
tual ejaculation time, which is 
in the normal range
demonstrated the immense taboo that exists among PE 
sufferers to openly talk about their PE. Because this taboo 
still exists today, it may be concluded that family studies 
on PE are also today practically impossible to perform.
　Fortunately, due to new developments in laboratory 
techniques of the past decade, DNA research has become 
easier to perform in many laboratory settings nowadays. 
After the first publication of a DNA study in Dutch men 
with lifelong PE by Janssen et al [4], a small number of oth-
er genetic studies on PE in different countries, in different 
cohorts of men, and with different methodologies have been 
published. However, many clinicians, particularly those 
who have not been educated with current knowledge of ge-
netics, have difficulties in understanding the details of ge-
netic research articles and the often complex associated 
statistics. The aim of the current article is to clarify and crit-
ically review the current methodologies that have been 
used in genetic research on lifelong PE in the context of re-
cent developments in diagnosis and classification. 
COMPLAINT VERSUS DISORDER
In 2006, Waldinger et al emphasized the need to distin-
guish PE as a “complaint” versus PE as a “disorder” [7,8]. 
This distinction has important consequences for both epi-
demiologic research on PE and for the debate on definition 
and classification. For example, most epidemiologic stud-
ies have reported PE to be the most prevalent male sexual 
“disorder” [9,10]. However, considering the questions that 
have been asked in these surveys, it appears that these sur-
veys only investigated the prevalence of males who have 
a “complaint” of PE. Therefore, it has to be concluded that 
PE is the most prevalent male sexual “complaint” affecting 
some 20% to 30% of men [7,8]. Until recently, the preva-
lence of PE as a sexual “disorder” has not been investigated 
in the general male population. However, the study of 
Serefoglu et al showed that in 20% of men with “complaint”s 
of PE, the prevalence of the sexual “disorder” of lifelong PE 
is rather low in the general male population [11].
FOUR PREMATURE EJACULATION SUBTYPES
The very high percentage of 20% to 30% of men in the gen-
eral male population who suffer from complaints of PE [8,9, 
11] contrasts with the rather low percentage of men who 
visit outpatient clinics for medical treatment of PE [12]. 
The argument to explain this low percentage by the ever- 
existing taboo to talk about PE probably only partially ex-
plains this remarkable difference. An additional expla-
nation has been put forward by Waldinger et al, who stated 
that the prevalence of 20% to 30% does not represent the 
number of men who suffer from lifelong or acquired PE 
[13-16]. Waldinger et al reported that in contrast with the 
high percentage of men who have complaints of PE without 
having a short ejaculation time of less than one minute, the 
prevalence of the disorders of lifelong and acquired PE with 
IELTs of less than one minute is rather low (2.5%) in the 
general male population [13-18]. Presuming that the per-
sistent, very short IELTs of less than one minute are a ma-
jor disturbing factor for a man’s self-esteem, sexual self- 
confidence, and feelings of masculinity, the rather low per-
centage of men who actively seek medical treatment most 
probably represents the rather low percentage of men with 
lifelong and acquired PE in the general male population. 
In 2006, Waldinger et al suggested that apart from the two 
well-known subtypes of PE (e.g., lifelong PE and acquired 
PE), there are also two other PE subtypes: natural variable 
PE and premature-like ejaculatory dysfunction (Table 1) 
[7,13]. In natural variable PE, men only occasionally suffer 
from early ejaculations. In premature-like ejaculatory dys-
function, men experience or complain of PE while actually 
having a normal or even a long IELT duration of, for exam-Korean J Urol 2011;52:1-8
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TABLE 2. Prevalences and self-reported mean and median IELT durations of the four PE subtypes in a turkish outpatient clinic of 
urology and in the general turkish male population [11,20]
Premature ejaculation 
subtype
Prevalence of PE in 
outpatient clinic
n=261 males
Self-reported mean 
IELT (range)
Prevalence in general Turkish 
male population (n=2,593). 
Males with PE (n=512; 20%) 
Self-reported 
median IELT 
Lifelong premature 
ejaculation
62.5% 20.47±28.90 s
(2 s-2 min)
2.3% ＜1 min
Acquired premature 
ejaculation
16.1% 57.91±38.72 s 
(1.5-3 min)
3.9% 1-2 min
Natural variable premature 
ejaculation
14.5% 144.17±22.47 s 
(2-3 min)
8.5% 2-3 min
Premature-like ejaculatory 
dysfunction
  6.9% 286.67-69.96 s 
(3-7 min)
5.1% ＞3 min
IELT: intravaginal ejaculation latency time
ple, 5 to 20 minutes [14-16]. The 4 PE subtypes are dis-
tinguished on the basis of the IELT duration. In the 1990s, 
Waldinger et al postulated that lifelong PE is mainly influ-
enced by neurobiological and genetic factors and showed 
that it is characterized by an IELT of less than 1 minute, 
usually within about 30 s [19]. Acquired PE is caused by 
either medical or psychological causes and is also charac-
terized by a short IELT, most probably between 1 and 2 mi-
nutes [14]. On the other hand, natural variable PE is con-
sidered a normal variation of ejaculatory performance and 
should not be regarded as an ejaculatory disorder. It has 
been presumed that the IELT in this subtype is in the nor-
mal range. Premature-like ejaculatory dysfunction is con-
sidered to be caused by psychological, cultural, or inter-
relationship factors and is not considered to be caused by 
neurobiological or genetic factors [14-16]. Its IELTs are in 
the normal range or even of longer duration. For a better 
understanding, premature-like ejaculatory dysfunction 
may also be denominated as subjective premature ejacula-
tion. Importantly, Waldinger emphasized that the four PE 
subtypes are characterized by different etiologies and have 
a different pathogenesis and therefore should be sepa-
rately defined [14-16]. He assumed that the prevalence of 
lifelong and acquired PE is probably low in the general male 
population but high in outpatient clinics of urology [14-16], 
whereas oppositely he also presumed that the prevalence 
of natural variable PE and premature-like ejaculatory dys-
function or subjective PE is high in the general male pop-
ulation but rather low in outpatient clinics of urology 
[14-16]. In addition, Waldinger argued that the sum of the 
prevalences of these four PE subtypes constitutes the 20% 
to 30% prevalence of PE as has often been found in epi-
demiologic studies [14-16]. 
　Interestingly, two studies by Serefoglu et al investigat-
ing the prevalence of the 4 PE subtypes in Turkey con-
firmed the existence of the 4 PE subtypes in both an out-
patient clinic of urology and in the general male population 
(Table 2) [11,20]. Moreover, the self-reported IELT values 
in their study indeed showed a continuum, with the short-
est IELTs in lifelong PE and the longest IELTs in subjective 
PE. Also, the prevalence rates of the 4 PE subtypes were 
in accordance with the hypothesis of Waldinger. The preva-
lence of lifelong PE was low in the general male population 
but very high in the outpatient clinic of urology, giving sup-
port to the validity of this new PE classification. However, 
more studies using the methodology of Serofoglu et al in 
other countries are warranted to further investigate the 
validity of this classification [11,20].
DEFINITION OF PREMATURE EJACULATION
Until 1980, PE was not officially defined. In the mid of the 
last century, when many PE sufferers were treated by psy-
choanalysis, psychoanalysts considered a man to have PE 
when he ejaculated within about 1 minute [13]. However, 
Masters and Johnson, two representatives of behaviorism, 
fiercely rejected this definition in terms of ejaculation time 
and considered a man to suffer from PE when he was not 
able to control his ejaculation until the moment that he 
gave pleasure to his partner [21]. Their opinion influenced 
the first official definition of PE in the DSM-III, in which 
PE was defined solely in terms of voluntary control [22]. 
However, in the DSM-III-R, DSM-IV, and DSM-IV-TR ver-
sions, control has been deleted and replaced by the criterion 
of a short ejaculation time, without specification of a cutoff 
point of this “short” ejaculation time [22]. During the past 
decade in particular, the DSM-IV-TR definition has been 
criticized for its vagueness [22,23], although some clini-
cians have also stated that the DSM-IV-TR definition of PE 
is adequate and does not require revision [24]. The debate 
on this definition came to an end when the International 
Society for Sexual Medicine (ISSM) organized a meeting 
of experts in the field to derive an evidence-based definition 
of PE [25].
DEFINITION OF LIFELONG PREMATURE 
EJACULATION
During this meeting in Amsterdam, the ISSM decided that 
there were sufficient data to define a new definition of life-Korean J Urol 2011;52:1-8
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long PE but still insufficient data for a new definition of ac-
quired PE [25]. The ISSM defined lifelong PE as an ejacu-
lation that occurs within about 1 minute after penetration 
in the majority of sexual encounters, with an inability to 
delay ejaculation and with associated negative personal 
consequences such as bother and avoidance of sexual activ-
ity [25]. Recently, the ISSM also organized a similar meet-
ing in order to derive an evidence-based guideline for the 
treatment of PE [26]. With both an evidence-based defi-
nition of lifelong PE and an evidence-based guideline for 
the treatment of PE, the ISSM has made an enormous, his-
torical contribution to the research and treatment of PE.
CENTRAL SEROTONERGIC MODULATION OF 
THE IELT
It has become clear from both human and animal studies 
that serotonin (5-hydroxytryptamine, or 5-HT) plays a very 
important role in sexual and particularly ejaculatory activ-
ity [27-31]. Animal studies, mainly performed in labo-
ratory rodents, have shown that various brain areas are 
specifically involved in ejaculatory behavior [32]. Overall, 
these brain areas are a complex interconnected network 
that regulates ejaculation. There is also a very important 
spinal ejaculation generator located lateral to the central 
canal in lamina X and in the medial portion of lamina VII 
of L3 and L4 of the lumbar spinal cord. These lumbar spino-
thalamic (LSt) neurons project to the medial parvocellular 
subparafascicular nucleus of the posterior thalamus 
(SPFp) and are specifically activated during ejaculation 
but not with other components of male rat sexual behavior 
[33]. Lesions of these neurons cause dramatic disruptions 
in ejaculatory behavior [33]. Serotonergic fibers have been 
found in all spinal cord areas containing sensory axons and 
motor neurons involved in ejaculation. They are present in 
the dorsal and ventral horns, dorsal commissural grey and 
thoracolumbar intermediolateral cell column (IML), and 
sacral parasympathetic nucleus (SPN) of the lumbosacral 
spinal cord [34]. In addition, serotonergic postsynaptic re-
ceptors have been found in the area where LSt cells are lo-
cated [35]. This suggests a role of serotonin in ejaculation 
via these possible connections in the spinal cord. However, 
these serotonergic connections are also found in supra-
spinal areas. In the nucleus paragigantocellularis (nPGI), 
an area in the ventrolateral medulla of the brainstem, sero-
tonergic neurons are found to innervate the bulbospongio-
sus muscles involved in the inhibition of ejaculation [35]. 
The medial preoptic area (MPOA) might lower the ejacu-
latory threshold by removing the tonic serotonergic in-
hibition exerted by the nPGI [36]. Another serotonergic in-
nervation exists in the anterior lateral hypothalamic area 
(LHA). Lesions of the LHA in male rats strongly affect the 
occurrence of ejaculations, showing the excitatory role of 
this brain region in the regulation of ejaculation [37]. This 
effect is caused by serotonin, because it is released in the 
LHA at the time of ejaculation [38], and injections of SSRIs 
into the LHA were shown to increase ejaculation latencies 
[38].
　The ejaculatory reflex is complex and involves multiple 
afferent and efferent systems. The afferent stimuli may in-
volve sensory, visceral, proprioceptive, and somatic inputs. 
It is possible that LSt cells receive stimuli related to the on-
set of ejaculation and, in turn, trigger the ejaculation reflex. 
The efferent site of the reflex involves the complex control 
of sympathetic and parasympathetic systems [33]. Briefly, 
ejaculation is a spinal reflex controlled by the spinal ejacu-
lation generator that is “modulated” by sensory input from 
the pelvis and descending input from inhibitory and ex-
citatory centers in the brainstem and the hypothalamus. 
Allard et al suggested that these supraspinal centers are 
controlled by cortico-limbic centers, which are responsible 
for switching on a state of sexual excitement [39]. During 
sexual intercourse, the cortico-limbic centers inhibit and 
activate the inhibitory and excitatory centers respectively, 
shifting the supraspinal tone to the spinal ejaculation gen-
erator from overall inhibitory to excitatory.
　All together, the data derived from animal research sug-
gest a major role of the central serotonergic system in mod-
ulating the spinal ejaculatory reflex. This serotonergic 
modulation of ejaculation may result in a faster or more de-
layed ejaculation, whereas the ejaculation itself is prob-
ably not under direct influence of the serotonergic system 
but rather under the influence of other neurotransmitter 
systems in the spinal cord [33]. This is an important con-
sequence of this central modulation of ejaculation that has 
hardly been discussed in the literature but may be pivotal 
for genetic research on PE. For example, it may be assumed 
that the modulation of ejaculation among men is variable; 
it can be strong, moderate, weak, or even absent. In the last 
case, the serotonergic system in the brainstem is unable to 
modulate the ejaculation reflex in the lower spinal cord. In 
that case, a male is not able to or hardly able to change the 
duration of his ejaculation time. Even by using SSRIs, this 
subject may still not be able to change the duration of his 
ejaculation time. Although never systematically inves-
tigated, it is clinically well known that a subgroup of men 
with lifelong PE do not respond with ejaculation delay to 
any SSRI treatment. I therefore suggest that in these men, 
the serotonergic system is unable to modulate the ejacu-
lation reflex. 
　The view that serotonin modulates ejaculation may have 
important implications for genetic research, because it may 
imply that in a certain cohort of men, an unknown number 
have no or hardly any ability to modulate ejaculation irre-
spective of the presence of functional serotonergic poly-
morphisms. Consequently, irrespective of the presence of 
these polymorphisms, these men will not show any change 
in IELT duration when modulation of the IELT is not 100% 
associated with such serotonergic polymorphisms. 
　This phenomenon may mask positive outcome data, par-
ticularly when the size of the cohort is small. In order to 
avoid this phenomenon, it may be argued that the odds of 
finding a positive association between serotonergic poly-
morphisms and the duration of the IELT is enhanced when Korean J Urol 2011;52:1-8
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genetic research is performed in men who develop an ejacu-
lation delay in response to daily SSRI, e.g., paroxetine, 
treatment. 
GENETICS OF IELT, LIFELONG PE, AND PE
It is important to distinguish (i) the genetics of the ejacu-
lation time (e.g., the IELT), (ii) the genetics of lifelong PE, 
and (iii) the genetics of PE. 
1. Genetics of the IELT
The aim of genetic research on the ejaculation time (e.g., 
IELT) is to investigate the genetic factors that influence or 
“modulate” the duration of the ejaculation time (e.g., the 
IELT). 
2. Genetics of lifelong PE
The aim of genetic research on lifelong PE is to investigate 
the genetic factors that influence or are involved in the vari-
ous parameters of lifelong PE. 
3. Genetics of PE
The aim of genetic research on PE is to investigate the ge-
netic factors that influence or are involved in men who com-
plain of PE and who have both normal and very short ejacu-
lation times. 
GENETICS AND THE FOUR PE SUBTYPES
It should be emphasized that according to Waldinger et al, 
only a very small percentage of men who “complain” of PE 
have “genetically” based PE [14-16]. This is explained by 
the following arguments. 
　(i) Of the four PE subtypes, it has been argued that only 
lifelong PE is mainly influenced by genetic and neurobio-
logical factors, because the IELT in these men persistently 
occurs within 1 minute independent of internal or environ-
mental circumstances. According to this view, the genetics 
of lifelong PE pertains only to the neurobiological mecha-
nisms that determine the “modulation” of the persistently 
very short IELTs. In the case of homosexual individuals 
with lifelong PE, the modulation of ejaculation is better re-
flected by the duration of the MELT, OELT, or AELT [40]. 
　(ii) The prevalence of men with an IELT of less than 1 mi-
nute, irrespective of a complaint of PE, in the general male 
population is about 2.5% [17,18].
　(iii) The prevalence of men with an IELT of less than 1 
minute and with a complaint of PE in the general male pop-
ulation is about 2.5% as well [11].
　According to Waldinger et al, the duration of the ejacu-
lation time (e.g., the IELT) is influenced by both genetic and 
nongenetic factors [14-16]. However, it is postulated that 
the genetic influences on the IELT become most manifest 
in men who persistently ejaculate within 1 minute, e.g., in 
men with lifelong PE. In contrast, with increasing genetic 
and neurobiological ability to delay ejaculation time, it is 
argued that nongenetic factors increasingly influence the 
IELT duration. 
　The aforementioned view is the basis for the hypothesis 
of Janssen et al [4] that the persistently short IELTs in men 
with lifelong PE are caused by (the sum of) various genetic 
polymorphisms or other genetic factors that facilitate 
ejaculation. According to the same view, it is assumed that 
the genetic profile of genetic polymorphisms in men with 
lifelong PE is different from the genetic profile of genetic 
polymorphisms in men with natural variable PE or sub-
jective PE, because the IELT duration in these men is not 
restricted to less than 1 minute.
THREE DIFFERENT METHODS OF GENETIC 
RESEARCH ON PREMATURE EJACULATION
So far, three different methods of genetic research on PE 
have been published. 
1. The first method investigates the genetics of the ejacu-
lation time (e.g., the IELT) in men with lifelong PE with 
IELTs of less than 1 minute [4]. This investigation is based 
on the hypothesis of Waldinger et al that the skewed dis-
tribution of the IELT in the general male population [17,18] 
in men with lifelong PE [4,19,41] and in any cohort of male 
Wistar rats [29] is based on genetic factors influencing the 
central serotonergic system in modulating the duration of 
the IELT. The methodology of this genetic research con-
sists of real-time, objective stopwatch measurement of the 
IELT in cohorts of men who actively seek medical treat-
ment for their complaints associated with lifelong PE in 
terms of lifelong, persistent IELTs of about 1 minute. 
2. The second method investigates the genetics of men who 
complain of PE in the general male twin population [42-45]. 
This investigation is based on the view of Jern et al that PE 
consists of various parameters (such as anteportal ejacu-
lation, number of thrusts, ejaculation latency time, and 
feelings of control) that are potentially genetically interre-
lated [42-45]. Their methodology of genetic research con-
sists of sending questionnaires to a large cohort of male ho-
mosexual and heterosexual twins irrespective of their wish 
to seek medical treatment for complaints of PE and without 
objective stopwatch measurements of the IELT. 
3. The third method investigates whether the prevalence 
of genotypes in men with lifelong PE in terms of an IELT 
of less than 1 minute differs from the prevalence of these 
genotypes in the general male population [46,47], without 
investigating potential associations of genetic poly-
morphism with the IELT (as used in the first method). This 
investigation is based on the view that men with lifelong 
PE have a different genotype profile than do men without 
lifelong PE.
DIFFERENCES BETWEEN THE THREE METHODS
The three methods differ in (i) the investigated population Korean J Urol 2011;52:1-8
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(men with lifelong PE versus general male twin population), 
(ii) tool of measurement (stopwatch versus questionnaire), 
(iii) design (prospective real-time IELT measurement ver-
sus retrospective IELT estimation), and (iv) variables 
(IELT versus feelings of control, ejaculation prior to inter-
course, number of thrusts, and ejaculation latency time). 
　However, the major difference between the three study 
designs pertains to the investigated population. Whereas 
Janssen et al investigated a selected cohort of men with life-
long PE who ejaculate within about 1 minute and who pres-
ent as patients actively seeking treatment [4], Jern et al 
and Santtilla et al investigated a relatively small group of 
respondents (40%; 33%) recruited from a large general 
male twin population who did not present as patients seek-
ing medical treatment [42-45]. 
　Moreover, in the studies of Jern et al and Santtilla et al, 
most (98%) of the male twins ejaculated after 1 minute [42- 
45]. Of 1,290 twins, only 26 (2%) twins reported an ejacu-
lation time of less than 1 minute [45]. In contrast, in the 
study of Janssen et al [4], most (92%) of the men ejaculated 
within 1 minute, and only 8% ejaculated between 1 and 2 
minutes. 
　The third method of genetic research on PE is different 
from the method of Janssen et al [4]. In this method, men 
with lifelong PE are selected but instead of investigating 
potential associations of genetic polymorphisms with the 
IELT, the prevalence of genotypes in these men with life-
long PE is compared with the prevalence of these genotypes 
in a control group. This method has been used by Ozbek et 
al and Luo et al in Turkey and China [46,47] . The outcome 
of these studies points to a different genetic profile in men 
with lifelong PE than in men in the general male pop-
ulation, rather than emphasizing an association between 
ejaculation time and genetic polymorphism. However, 
such a difference in genotype profile was not found in the 
Dutch study of men with lifelong PE by Janssen et al [4]. 
This discrepancy was explained after re-analysis of the da-
ta by Ozbek et al [46], which disclosed that these study pop-
ulations did not meet Hardy-Weinberg equilibrium, in-
dicating laboratory insufficiencies or patient selection bias 
[48]. Further studies controlled by Hardy-Weinberg equili-
brium are needed to elucidate whether men with lifelong 
PE indeed have a higher prevalence of certain genotypes 
than do males in the general male population. 
LIMITATIONS OF THE THREE METHODS
Each of the three methods has its own limitations. For ex-
ample, non-stopwatch assessment of the IELT in the gen-
eral male population may give rise to about 30% over- and 
under-estimation of the IELT compared with stopwatch 
assessment [18]. Therefore, it may be assumed that the 
non-stopwatch methodology of Jern et al [42-44] and 
Santtilla et al [45] fails to precisely objectify the IELT dura-
tion both in men with an IELT of less than 1 minute and 
in men with longer IELT durations. Notably, any question-
naire method as has been used by Jern et al and Santtilla 
et al is inadequate to investigate the subtle influences of 
genetic polymorphisms on the IELT in men with lifelong 
PE who ejaculate within 1 minute [42-45].
　On the other hand, the methodology of Janssen et al is 
inadequate to provide an answer to the question of how ge-
netic factors relating to ejaculation are distributed in the 
general male population [4]. In addition, the design and 
method of the study of Janssen et al do not have the pre-
cision needed to study associations between subjective feel-
ings of control and genetic polymorphisms [4]. The small 
number of participants in stopwatch studies in general 
does not allow sufficient power to analyze subjective feel-
ings and possible polymorphisms. Such studies would re-
quire a huge cohort of patients.
THE NEED FOR STOPWATCH MEASUREMENTS 
IN GENETICS
Interestingly, the current different views on how to per-
form genetic research on PE are strikingly similar to the 
different views that existed in the 1990s on how to perform 
drug treatment research on PE [49]. Also in that decade, a 
number of clinicians favored the stopwatch method to pre-
cisely assess the IELT, whereas others used question-
naires to measure control, satisfaction, and ejaculation 
time [49]. However, a final meta-analysis of drug treat-
ments that were mainly performed in the 1990s confirmed 
that real-time, prospective stopwatch measurement of the 
IELT is more accurate than retrospective IELT assess-
ments [2]. Similarly, it is my current view that real-time 
prospective IELT measurement is pivotal for evidence- 
based genetic research on PE, acknowledging that this re-
quirement may impede large-scale genetic research of the 
IELT in the general male population. 
CONCLUSIONS
A substantial number of men in the general population 
have complaints of PE. However, only a minority of these 
men are affected by the disorder of lifelong PE or acquired 
PE, both of which are characterized by a very short ejacu-
lation time. Notably, particularly men with the latter PE 
subtypes most frequently seek medical treatment for their 
complaints of PE. On the other hand, men with natural var-
iable PE and particularly those with premature-like ejacu-
latory dysfunction or subjective PE complain of PE, where-
as their ejaculation time is actually not aberrant from the 
average ejaculation time in the general male population. 
For genetic research on PE, it is pivotal to take into account 
the different etiologies and pathogenesis of the four PE 
subtypes. For example, if it appears that subjective PE is 
more associated with social anxiety or specific personality 
traits than is lifelong PE, then genetic factors associated 
with social anxiety or these personality traits may more fre-
quently be found in men with subjective PE. By not differ-
entiating the 4 PE subtypes in genetic research, the odds 
will be increased that genetic outcome data (for example, Korean J Urol 2011;52:1-8
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a genetic association with personality traits) will in-
correctly be generalized to PE subtypes that are not asso-
ciated with these outcome data. In addition, the odds will 
be increased that outcome data that have been found in a 
subtype of PE with a low prevalence (e.g., lifelong PE) are 
not found in the rest of the investigated cohort and there-
fore will incorrectly be dismissed. Moreover, the odds that 
the aforementioned examples may happen is absolutely in-
creased when measurement of the duration of the IELT is 
not included in the study design or is inadequately as-
sessed, for example, by a questionnaire instead of with a 
stopwatch. 
　Currently, three methods are used to perform genetic re-
search on PE. The three methods differ in the investigated 
population, tool of measurement, study design, and varia-
bles of PE. The small number of genetic studies on PE that 
have so far been published do not yet allow a conclusion as 
to which of these methods is the most valid. However, as 
previously mentioned, it is this author’s view that pro-
spective stopwatch measurement of the IELT is pivotal for 
evidence-based genetic research on the IELT in men with 
lifelong PE and the three other PE subtypes. Moreover, it 
is emphasized that in finding associations between seroto-
nergic polymorphisms and the IELT duration in men with 
lifelong PE, the central serotonergic system is mainly in-
volved in the “modulation” of the ejaculation or IELT and 
not or just minimally in the spinal ejaculation reflex itself. 
Because this modulation of the IELT is variable among 
men and may even be absent, serotonergic polymorphisms 
may only be found in men who respond to SSRI treatment 
with an ejaculation delay.
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